Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!

Liquid biopsy is a rapidly emerging field due to an increasing number of oncogenic drivers and a better understanding of resistance mechanisms to targeted therapies in non-small cell lung cancer (NSCLC). The sensitivity of the most widely used blood-based assays is, however, limited in particular in...

Descripción completa

Detalles Bibliográficos
Autores principales: Durin, Lucile, Pradines, Anne, Basset, Céline, Ulrich, Bryan, Keller, Laura, Dongay, Vincent, Favre, Gilles, Mazieres, Julien, Guibert, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698102/
https://www.ncbi.nlm.nih.gov/pubmed/33207539
http://dx.doi.org/10.3390/cells9112486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698102/
https://www.ncbi.nlm.nih.gov/pubmed/33207539
http://dx.doi.org/10.3390/cells9112486

Ejemplares similares